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1. Introduction
Aging of the human body is associated with a gradual loss of
muscle mass (sarcopenia). In some cases, a critically low muscle
mass, together with reduced muscle function, will result in frailty,
which is a powerful predictor of mortality (Fried et al., 2001). Part
of the loss of muscle mass is clearly associated with reduced levels
of physical activity and muscle disuse. However, individuals who
maintain a high level of physical activity throughout life do
experience some loss of skeletal muscle mass, indicating that
exercise cannot completely prevent the age-related decline in
muscle mass (Faulkner et al., 2008). The explanation for this
remains unknown, but factors like neuro-muscular impairment,
cell membrane changes or altered intracellular signaling have been
demonstrated to play a role in animal models (Andersson et al.,
2011; Burks et al., 2011; Narici and Maffulli, 2010). However, a
comprehensive explanation for sarcopenia in humans is still
lacking. A decline in adaptive immunity, or the development of
low-grade inflammation with elevated levels of inflammatory
markers, possibly derived from adipose tissue, may play a role
(Lutz and Quinn, 2012). With regard to systemic inflammation,
elevated circulating levels of the acute phase protein C-reactive
protein (CRP) and cytokines, such as tumor necrosis factor alpha
(TNFa) and interleukin 6 (IL-6), have been found in elderly
individuals (Bruunsgaard et al., 2000) and these factors have been
reported to be related to mortality (Harris et al., 1999). Similarly,
the soluble urokinase plasminogen activator receptor (suPAR),
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A B S T R A C T
Human aging is associated with a loss of skeletal muscle and an increase in circulating inflammatory
markers. It is unknown whether endurance training (Tr) can prevent these changes. Therefore we
studied 15 old trained (O-Tr) healthy males and, for comparison, 12 old untrained (O-Un), 10 Young-Tr
(Y-Tr) and 12 Young-Un (Y-Un). Quadriceps size, VO2 peak, CRP, IL-6, TNF-a and its receptors, suPAR,
lipid profile, leucocytes and glucose homeostasis were measured. Tr was associated with an improved
insulin profile (p < 0.05), and lower leucocyte (p < 0.05) and triglyceride levels (p < 0.05), independent
of age. Aging was associated with poorer glucose control (p < 0.05), independent of training. The age-
related changes in waist circumference, VO2 peak, cholesterol, LDL, leg muscle size, CRP and IL-6 were
counteracted by physical activity (p < 0.05). A significant increase in suPAR with age was observed
(p < 0.05). Most importantly, life-long endurance exercise was associated with a lower level of the
inflammatory markers CRP and IL-6 (p < 0.05), and with a greater thigh muscle area (p < 0.05),
compared to age-matched untrained counterparts. These findings in a limited group of individuals
suggest that regular physical endurance activity may play a role in reducing some markers of systemic
inflammation, even within the normal range, and in maintaining muscle mass with aging.
! 2013 Elsevier Ireland Ltd. All rights reserved.
Abbreviations: CRP, C-reactive protein; HDL, high density lipoprotein; HOMA-IR,
homeostatic model assessment – insulin resistance; IL-6, interleukin 6; IPAQ,
International Physical Activity Questionnaire; LDL, low density lipoprotein; MET,
metabolic equivalent of task; MRI, magnetic resonance image; OGTT, oral glucose
tolerance test; Q-CSA, quadriceps cross sectional area; QUICKI, quantitative insulin
sensitivity check index; sTNFR, soluble TNF receptor; suPAR, soluble urokinase
plasminogen activator receptor; Tr, trained; TNF-a, tumor necrosis factor alpha;
Un, untrained; VO2 peak, peak oxygen consumption.
* Corresponding author at: Institute of Sports Medicine Copenhagen, Bispebjerg
Hospital, Bldg 8, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.
Tel.: +45 3531 5059; fax: +45 3531 2733.
E-mail address: ullaramer@hotmail.com (U.R. Mikkelsen).
1 These authors contributed equally to this work.
Contents lists available at ScienceDirect
Mechanisms of Ageing and Development
jo ur n al ho mep ag e: www .e lsev ier . c om / lo cate /m ec hag ed ev
0047-6374/$ – see front matter ! 2013 Elsevier Ireland Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.mad.2013.11.004
which is also a marker of systemic low-grade inflammation, has
been found to be associated with age, chronic diseases, cancer and
mortality (Eugen-Olsen et al., 2010; Langkilde et al., 2011).
Inflammation is considered to play a role in disease develop-
ment and prognosis (Toth et al., 2006; Visser et al., 2002), and high
levels of inflammatory markers are associated with an increased
risk of development of cardiovascular disease and cancer (Allin
et al., 2010; Wensley et al., 2011). In addition, obesity and visceral
adiposity are positively associated with elevated cytokine levels
(TNFa and IL-6) and CRP (Park et al., 2005). A reduction in trunk fat
induced by 10 months of cardiovascular exercise training was
significantly related to a drop in circulating CRP levels (Vieira et al.,
2009). SuPAR in the general population is not uniformly related to
obesity and visceral adiposity but is associated with an increased
risk of cardiovascular disease (Lyngbaek et al., 2013a).
Several large cohort studies have found a relationship between
self-reported physical activity levels and systemic markers of
inflammation: higher levels of physical activity are coupled to
lower levels of circulating inflammatory markers in elderly
individuals (Taaffe et al., 2000; Geffken et al., 2001; Wannamethee
et al., 2002; Reuben et al., 2003; Colbert et al., 2004; Albert et al.,
2004; Rahimi et al., 2005; Yu et al., 2009; Valentine et al., 2009;
Elosua et al., 2005). This coupling was also evident after
adjustment for other risk factors and persisted even with relatively
low levels of physical activity (Elosua et al., 2005). Aerobic fitness
was inversely associated with inflammatory biomarkers in persons
above 60 years (Taaffe et al., 2000; Valentine et al., 2009; Rahimi
et al., 2005). Intervention studies have shown that physical
training over several months reduces circulating levels of CRP and
IL-6 in some (Kohut et al., 2006; Vieira et al., 2009; Campbell et al.,
2009) but not all studies (Nicklas et al., 2005, 2008; Hammett et al.,
2004; Lund et al., 2011). It is important to note that these
intervention studies were performed in patient groups or in
persons that had several risk factors, and thus all had relatively
high levels of inflammatory markers to begin with. Most of the
studies demonstrated that training induced a reduction in chronic
inflammation and weight loss, but one study (Nicklas et al., 2008)
showed that regular aerobic exercise training was efficient in
lowering IL-6 levels even without weight loss.
The aim of the present study was to investigate the influence of
life-long endurance exercise on the levels of inflammatory markers
and muscle size in healthy, normal-weight young and elderly
males. We used endurance trained individuals (long-distance
runners) as the active group of subjects, either young endurance
athletes or elderly master athletes in order to obtain data from
individuals who were healthy and had performed regular training
for most of their life. As healthy control individuals we used
untrained, weight-matched males for the respective age groups.
We hypothesized that age and life-long endurance training
would affect systemic inflammatory levels and muscle size, and
that small differences in circulatory inflammatory markers would
be inversely related to muscle size. Inflammatory biomarkers were
determined from circulating blood, and muscle size and function
were measured. In addition, blood lipid profile, glucose homeo-
stasis and body composition were determined to evaluate any
potential coupling of these parameters to aging and endurance
training.
2. Methods
2.1. Subjects
We recruited a total of 49 males: 15 male endurance runners (master athletes,
old trained, O-Tr; running distance of 49 ! 3 km/wk (4–6 training days/wk) over the
last 28 ! 2 years (mean ! SE)), 12 old untrained weight matched healthy controls (O-
Un), and 10 young males matched for current running distance to the old trained
(young trained, Y-Tr; 43 ! 5 km/wk (4–6 training days/wk), endurance runners during
the last 6 ! 1 years) and 12 young untrained weight matched controls (Y-Un). The
untrained subjects had been sedentary for at least five years and they currently did not
perform any regular physical activity. The trained individuals were all endurance
runners. Moreover, neither the trained or the untrained had any physically demanding
occupational jobs, thus their physical activity level was primarily governed by their
leisure time activities. All subjects were healthy normotensive (<140/90 mmHg) and
non-obese (BMI < 28), did not take any prescription medication, had no overt signs or
symptoms of diabetes, pre-diabetes or atherosclerosis, and had no known joint, muscle
or tendon pathology. The O-Un group was selected to represent a healthy age matched
but untrained group to separate out the exercise component as much as possible
during the aging process. Before the test days, subjects abstained from caffeine and
fasted overnight to be studied in the post-absorptive state. Subjects were studied at
least 24 h after their last running session to avoid the acute effects of exercise but they
were still considered to be in their habitual training state. The ethics committee of the
Capital Region of Denmark approved this study (journal number 25543), and all
procedures conformed to the Declaration of Helsinki. Written, informed consent was
obtained from all subjects before the study.
2.2. Study design
On the first test day, subjects arrived fasted in the morning and blood samples
were obtained. An oral glucose tolerance test (OGTT) was performed, anthropo-
metrics were measured and questionnaires filled in. Finally a magnetic resonance
image (MRI) scan of the thigh was performed to assess the cross-sectional area
(CSA) of the quadriceps muscle. On the second test day, subjects arrived, again
overnight-fasted. Muscle strength (maximal voluntary contraction, MVC) was
measured. One hour after consuming a light sandwich, fruit and water, maximal
oxygen consumption was measured. Test days 1 and 2 were consecutive days.
2.3. Subject characteristics and physical activity level
Waist circumference was measured as the smallest circumference between
anterior superior iliac spine and the lower ribs, to the nearest mm. Height was
measured to the nearest mm and weight to the nearest 100 g, wearing light clothes
and without shoes, and body mass index (BMI) was calculated.
To quantify the physical activity level of the subjects, the International Physical
Activity Questionnaire (IPAQ) was used (Craig et al., 2003). The IPAQ questionnaire
quantifies the physical activity level of the subjects as the average weekly MET
(metabolic equivalent of task)-score, MET-minutes/week. One
MET = 1 kcal kg"1 h"1 is equivalent to the resting metabolic rate (RMR) obtained
during quiet sitting (Ainsworth et al., 2011). WHO (World Health Organization) has
defined a weekly MET-score below 600 as low physical activity level and above
3000 as a high physical activity level. We also used a Danish questionnaire, which
has been used in several large scale investigations of health and disease status
among the Danish population (Sundhed & Sygelighed, SUSY, www.sst.dk), to assess
the sedentary time of the subjects.
2.4. Muscle size, strength and exercise performance
The anatomical cross sectional area of the quadriceps femoris muscle (Q-CSA)
was measured 20 cm proximal to the tibia plateau (mid-thigh level) by magnetic
resonance imaging (MRI) (General Electric, Sigma Horizon LX 1.5 Tesla, T1 weighted
SE) using a lower extremity coil. The images were obtained using the following
parameters: TR/TE = 500/14 ms, FOV 18, matrix 512 # 512 and slice thick-
ness = 6 mm. Subsequently, the lean muscle mass of the quadriceps muscle
(subcutaneous and intermuscular non-contractile tissue were excluded in the
measurement) was manually outlined (see Fig. 1A) using a DICOM file viewer and
associated measurement software Osirix 2.7.5 (OsiriX medical imaging software,
Geneva, Switzerland). The same experienced investigator completed the analysis
twice (blinded to the group of the subject) and the average of these two
measurements was used.
Strength of the quadriceps muscle was determined as the maximum knee
extensor moment during a 10 sec ramp contraction. Subjects performed a 5-min
warm-up on a stationary bike. Thereafter the subjects were seated in a custom
made rigid chair with both hips and knees flexed to an angle of 908. A leg cuff, which
was connected to a strain gauge (Bofors KRG-4, Bofors, Sweden) through a rigid
steel rod perpendicular to the lower leg, was mounted on the leg just above the
medial malleolus. Subjects performed 4–5 isometric knee extension ramps by
applying gradually increasing force until maximum. Each ramp contraction was
separated by a one-minute rest period. All measurements were performed by one
leg (non-dominant). During the contractions, force was sampled at 1500 Hz
(Noraxon Inc.). Tibia moment was measured (from the point of fixation to the lateral
epicondyle of the knee) to calculate the knee extensor moment.
Peak oxygen consumption was measured on a Monark electronically braked
ergometer bike (Monark 839 Ergomedic, Proterapi, Brøndby, Denmark) using an
incremental protocol with a 25 W increase in load every minute, starting at 50 W
(O-Un) or 75 W (all other groups) until volitional exhaustion, which was reached
between 4 and 12 min for all subjects. Subjects were instructed to aim at a pedalling
frequency of approximately 80–90 revolutions per minute (RPM), and were verbally
encouraged to perform their max. Oxygen consumption (VO2), CO2 excretion,
respiratory exchange ratio (RER), heart rate (HR), minute ventilation (VE) and
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Fig. 1. Muscle size, strength and exercise performance. (A) Quadriceps cross-sectional area (Q-CSA), (B) quadriceps muscle strength and (C) peak oxygen uptake in the four
different subject groups. Data are shown as mean + SE. (A) Upper panel: Magnetic resonance image (MRI) of the quadriceps muscle of young (top row; Y-Un (left) and Y-Tr
(right)) and old (bottom row; O-Un (left) and O-Tr (right)) subjects used to quantify Q-CSA. The images were obtained at mid-thigh level, 20 cm proximal to the tibia plateau.
The lean muscle mass of the quadriceps muscle was manually outlined as shown by the drawn lines, excluding subcutaneous and intermuscular non-contractile tissue. Scale
bar = 10 cm, 1 cm per indentation. Lower panel: Quantification of Q-CSA as measured by MRI. Q-CSA was significantly influenced by age (A, p < 0.001) and training (T,
p < 0.001), p-values for these main effects are given in figure. N = 12 in Y-Un, 10 in Y-Tr, 11 in O-Un and 12 in O-Tr. *p < 0.001 for difference between O-Un and O-Tr. (B)
Quadriceps muscle strength was determined as maximum knee extensor (KE) moment during a 10 s ramp contraction and significant main effects of age (A, p < 0.05) and
training (T, p < 0.01) were observed, as well as a significant interaction (A#T, p < 0.05) with Y-Tr being significantly stronger than O-Tr and Y-Un, *p < 0.05. N = 10–15 as
given in Table 1. (C) Peak oxygen consumption (VO2 peak) was determined as the highest value reached during a 15 s period, and shown as fitness level (ml O2/kg/min).
Significant effects of age (A) and training (T) were observed, p-values are given in figure. N = 10–15 as given in Table 1.
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cadence (RPM) were continuously recorded (breath-by-breath) using Masterscreen
CPX equipment (Care Fusion, San Diego, CA). All subjects reached RER values above
1.09 (range 1.09–1.34), indicating that high exertion levels were obtained. Peak
oxygen uptake (VO2 peak) was determined as the highest value reached during a
15 s period (ignoring the highest and lowest value within that interval), and given
as absolute values (ml O2/min) and fitness level (ml O2/kg/min).
2.5. Blood samples
Fasted blood samples were drawn from an antecubital vein. For analyses of
insulin, CRP, IL-6, TNFa and its soluble receptors and suPAR, whole blood was
drawn into EDTA tubes and cooled on ice for 10 min, followed by centrifugation
(10 min at 3060 # g at 4 8C), and the plasma phase was stored at "80 8C until
analysis.
For analyses of sTNFRI and sTNFRII, whole blood was drawn into clot activator
tubes and allowed to clot at room temperature for 30 min followed by
centrifugation (10 min at 3060 # g at 4 8C), and the serum phase was stored at
"80 8C until analysis.
2.5.1. Blood lipid profile
Blood lipid profile (triglycerides, total cholesterol, high-density lipoprotein
(HDL) and low-density-lipoprotein (LDL) cholesterol) was determined at the
Clinical Biochemistry Department, Bispebjerg Hospital, Copenhagen. These blood
samples were collected into vacutainers and analysed no more than 2 h after the
time of collection, according to the laboratory standard operating procedures
(Nordin et al., 2004). Authorized lab-technicians handled the analyses. Cholesterol,
LDL, HDL, and triglyceride concentrations were measured by a colorimetrical slide
test in a Vitros 5.1 FS (Ortho Clinical Diagnostics, Raritan, New Jersey, USA) (Sennels
et al., 2011, 2012).
2.5.2. Glucose homeostasis
A glucose tolerance test was performed by oral administration of 75 g of glucose
dissolved in water. Glucose and insulin were analysed in blood samples obtained
before glucose ingestion, and glucose levels were determined after 2 h. Blood
glucose concentration was measured by use of a colorimetric slide test on Vitros 5.1
FS (Ortho Clinical Diagnostics, Raritan, New Jersey, USA). HbA1c was measured
using an ion-exchange high-performance liquid chromatography method (Osoh
G8-Tosoh Bioscience, Yamaguchi, Japan) (Dunn et al., 1979; Mosca et al., 1986).
Both blood glucose concentration and HbA1c were determined at the Clinical
Biochemistry Department, Bispebjerg Hospital, Copenhagen, where lab-technicians
handled the analyses.
Plasma insulin concentration was measured using a standard insulin ELISA kit,
K6219 (Dako Denmark A/S, Glostrup, Denmark). The homeostatic model assess-
ment (HOMA) used to quantify insulin resistance (HOMA-IR) was calculated from
fasting glucose and insulin as follows: HOMA-IR = (glucose in mmol/l # insulin in
mU/l)/22.5. The quantitative insulin sensitivity check index (QUICKI) was derived
from fasting insulin and fasting glucose as follows: QUICKI = 1/(log(insulin mU/
mL) + log(glucose mg/dL)).
2.5.3. Systemic inflammatory markers
Leucocyte concentrations were measured at the Clinical Biochemistry Depart-
ment, Bispebjerg Hospital, by optical spread light in a Sysmex XE (Sysmex, Kobe,
Japan) (Sennels et al., 2011).
For analyses of plasma C-reactive protein (CRP), an ELISA was developed with the
DuoSet DY1707 (R&D Systems, Minneapolis, MN, USA) and the coefficient of
variation (CV) was: intra-plate 1.1–3.1%, inter-plate 7–10%. The following ELISA kits
were used for measuring IL-6, TNFa and its soluble receptors, sTNFRI and sTNFRII:
IL-6 (Human IL-6 Quantikine HS ELISA Kit HS600B), TNFa (HSTA00D), sTNFRI
(DRT100) and sTNFRII (DRT200), all R&D systems. TNFa, IL-6 and CRP were
measured in plasma and sTNFRI & sTNFRII in serum.
The soluble urokinase-type plasminogen activator receptor (suPAR) was
measured in plasma using a commercially available sandwich ELISA-kit (ViroGates
A/S, Birkerød, Denmark), according to the manufacturer’s instructions. All samples
were measured in duplicate, and the mean suPAR concentration of the two
measurements was used for analysis. The variance between the two measurements
was within the acceptable variance of 10% (range 0.0–7.8%).
2.6. Statistics
Effects of age (A), training (T) and age # training interaction (A#T) were tested
using two-way ANOVA, with Holm–Sidak multiple comparison post hoc testing,
unless otherwise stated. When a significant interaction was observed, the post hoc
test was used to examine effects of training within the old (O-Tr vs O-Un), training
within the young (Y-Tr vs Y-Un), age within the trained (O-Tr vs Y-Tr) and age
within the untrained (O-Un vs Y-Un). Since the question whether life-long
endurance training could preserve muscle mass was central to the study, the
difference in Q-CSA between O-Un and O-Tr was tested using an unpaired t-test.
Blood protein data (insulin, CRP, IL-6, suPAR, TNFa and sTNFRI & II) were log-
transformed before statistical analyses. Age, IPAQ and sedentary time data were
analysed using the non-parametric one-way ANOVA (Kruskal–Wallis) test, with
Dunn’s multiple comparison post hoc test to compare selected groups, as listed
above. Height, weight, BMI and waist circumference were analysed using an
ordinary one-way ANOVA with Sidaks multiple comparison post hoc test to
compare selected groups, as listed above. Data are given as mean (SD) or mean (SE),
as stated in the results section. SigmaPlot version 12.4 (Systat Software Inc) and
Graph Pad Prism version 6 (GraphPad Software Inc, La Jolla, CA, USA) were used for
statistical analyses. The level of statistical significance is given as either p < 0.05,
p < 0.01 or p < 0.001.
3. Results
3.1. Subject characteristics (Table 1)
Anthropometric data for the subjects revealed 4 groups of
normal weight, non-obese individuals. BMI was slightly higher in
O-Un than in O-Tr (Table 1). Waist circumference was higher in (O-
Un) than both O-Tr (*) and Y-Un (§) (Table 1).
3.2. Physical activity (Table 1)
Habitual running distance per week (mileage in km) was similar
in the O-Tr (49 ! 3 km/wk) and Y-Tr (43 ! 5 km/wk NS) groups
(Table 1). Likewise, running distance during the last week prior to the
Table 1
Subject characteristics and physical activity.
Variable Young untrained Y-Un Young trained Y-Tr Old untrained O-Un Old trained O-Tr p-Value
Subject characteristics Mean (SD)
N 12 10 12 15
Age (years) 24 (3)§ 26 (4)# 66 (4) 64 (4) p < 0.001, K–W
Height (cm) 178 (6) 179 (4) 175 (4) 176 (5) NS
Weight (kg) 70 (8) 73 (6) 75 (4) 71 (6) NS
BMI (kg/m2) 22 (2)§ 23 (2) 25 (2) 23 (2) p < 0.05
Waist circumference (cm) 80 (5)§ 79 (5) 90 (4)* 83 (5) p < 0.001
Physical activity Mean (SE)
Running distance/wk (km) 43 (5) 49 (3)
Running distance last week (km) 48 (7) 43 (5)
Running years 6 (1) 28 (2)
IPAQ (MET-min/week) 919 (199)y 3724 (579) 1277 (575)* 8881 (1791) p < 0.001, K–W
Sedentary time (min/d) 560 (34) 489 (48) 520 (61) 384 (71) p < 0.05, K–W
Subject characteristics and physical activity level are shown for the four groups of subjects. p-Values from one-way ANOVA are given. For further details, see text. K–W;
Kruskal–Wallis test.
* Different from O-Tr (p < 0.05).
y Different from Y-Tr (p < 0.05).
# Different from O-Tr (p < 0.05).
§ Different from O-Un (p < 0.05).
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study was similar between these groups (O-Tr 43 ! 5; Y-Tr
48 ! 7 km/wk, NS). The O-Tr had been running for 28 ! 2 years
and the Y-Tr for 6 ! 1 years (Table 1). Physical activity level assessed
by IPAQ was higher in O-Tr than in O-Un (p < 0.001) and in Y-Tr than
in Y-Un (p < 0.05), but similar between O-Tr vs Y-Tr and O-Un vs Y-Un
(NS). A significant overall difference between the groups was found
with respect to sedentary time, but none of the selected comparisons
were significant.
3.3. Muscle size, strength and exercise performance (Fig. 1)
Quadriceps muscle cross sectional area (Q-CSA) was larger in
the young than old (main effect of age, A, p < 0.001) and in the
trained than the untrained (main effect of training, T, p < 0.001,
Fig. 1A). Among the old groups O-Tr had significantly larger Q-CSA
than O-Un (p < 0.001). Quadriceps muscle strength (Fig. 1B)
revealed a significant interaction between age and training (A#T,
p < 0.05) with Y-Tr being stronger than both Y-Un and O-Tr
(p < 0.05). Peak oxygen consumption (ml O2/min) and fitness level
(ml O2/kg min) (Fig. 1C) were both higher in the young compared
to the old (A, p < 0.001) and in the trained compared to the
untrained (T, p < 0.001) whereas no significant interaction
between age and training was observed.
3.4. Blood lipid profile (Table 2)
Training was associated with a lower level of triglyceride (T,
p < 0.001), total cholesterol and LDL cholesterol level (T, p < 0.01).
For triglycerides no effect of aging per se was demonstrated,
whereas aging was associated with a rise in total cholesterol, HDL
and LDL (A, p < 0.01).
3.5. Glucose homeostasis (Table 3)
Fasted insulin levels were lower in the trained groups than in
the untrained (T, p < 0.001), but unaffected by age (Table 3).
Fasting glucose was lower in the young than in the old groups (A,
p < 0.001). An interaction was observed (A#T, p < 0.05) with
fasted glucose being lower in O-Tr vs O-Un (*) and in Y-Un than in
O-Un (§). Likewise, blood glucose 2 h after glucose ingestion and
glycosylated hemoglobin (HbA1c) were lower in the young than in
the old groups (A, p < 0.01), but were unaffected by training.
Insulin resistance assessed by HOMA-IR was lower in the trained
than in the untrained groups (T, p < 0.001), and was not affected by
age, and in accordance, insulin sensitivity assessed by QUICKI was
higher in the trained than in the untrained groups (T, p < 0.001),
and not affected by age (Table 3).
3.6. Systemic inflammatory markers
There was a significant effect of age and training for CRP and IL-
6, and the level of inflammatory markers was lower in the young
compared to the old (A, p < 0.01) and in the trained compared to
the untrained groups (T, p < 0.001, Fig. 2). SuPAR was higher in the
old vs young groups (A, p < 0.001, Fig. 2), and the interaction
between age and training approached significance (A#T,
p = 0.054). As shown in Fig. 3, an age-training interaction was
present for TNFa (A#T, p < 0.05) and the old trained had higher
TNFa than old untrained (p < 0.05). The level of sTNFRI was lower
in the young groups compared to the old groups (A, p < 0.05), and
in the trained groups compared to the untrained groups (T,
p < 0.05). Likewise, serum sTNFRII was lower in the young groups
compared to the old groups (A, p < 0.05), but no effect of training
Table 2
Blood lipid profile and leucocytes.
Variable Young untrained Y-Un Young trained Y-Tr Old untrained O-Un Old trained O-Tr p-Value
A = age
T = training
Interaction
age # training
Blood lipid profile Mean (SE)
Triglycerides (mmol/l) 1.21 (0.20) 0.73 (0.06) 1.24 (0.15) 0.70 (0.04) T < 0.001
Total cholesterol (mmol/l) 5.18 (0.42) 4.44 (0.19) 6.67 (0.27) 5.76 (0.24) A < 0.001
T < 0.01
HDL cholesterol (mmol/l) 1.44 (0.07) 1.49 (0.08) 1.60 (0.11) 1.93 (0.09) A < 0.01
(T = 0.051)
LDL cholesterol (mmol/l) 3.20 (0.39) 2.61 (0.15) 4.51 (0.22) 3.51 (0.18) A < 0.001
T < 0.01
Leucocytes Mean (SE)
Leucocytes (x10^9/L) 6.59 (0.38) 4.69 (0.36) 5.65 (0.40) 5.07 (0.24) T < 0.001 (A#T = 0.074)
Data on blood lipid profile and leucocytes are shown for the four groups of subjects. p-Values for significant main effects of age (A), training (T) and interaction (A#T) are given.
For further details, see text.
Table 3
Glucose homeostasis.
Variable Young untrained Y-Un Young trained Y-Tr Old untrained O-Un Old trained O-Tr p-Value
A = age
T = training
Interaction
age # training
Glucose homeostasis Mean (SE)
Insulin (fasted, pmol/l) 22.8 (2.8) 14.9 (1.9) 26.0 (2.4) 13.9 (1.1) T < 0.001
Glucose (fasted, mmol/l) 4.58(0.10)§ 4.66 (0.11) 5.26 (0.10)* 4.91 (0.09) A < 0.001 A#T < 0.05
Glucose (2 hrs, mmol/l) 4.70 (0.15) 4.49 (0.34) 5.53 (0.20) 5.05 (0.27) A < 0.01
HbA1c (mean mmol/l) 5.51 (0.15) 5.58 (0.16) 6.45 (0.11) 6.03 (0.16) A < 0.001
HOMA-IR 0.78 (0.11) 0.53 (0.09) 1.02 (0.10) 0.51 (0.04) T < 0.001
QUICKI 0.41 (0.01) 0.44 (0.01) 0.39 (0.01) 0.44 (0.01) T < 0.001
Data on glucose homeostasis are shown for the four groups of subjects. p-Values for significant main effects of age (A), training (T) and interaction (A#T) are given. For further
details, see text.
* Different from O-Tr (p < 0.05).
§ Different from O-Un (p < 0.05).
U.R. Mikkelsen et al. / Mechanisms of Ageing and Development 134 (2013) 531–540 535
was observed (Fig. 3). Leucocyte levels in the endurance trained
groups were significantly lower than in the untrained groups (T,
p < 0.001), and the level was not affected by age (Table 2).
4. Discussion
To the best of our knowledge, this is the first study to
investigate the interaction between the influence of aging and
physical activity on inflammatory biomarkers and skeletal muscle
mass in elderly master athletes. One of the major findings of the
present study was that life-long endurance exercise was associated
with a larger muscle size than O-Un and an attenuation of the age-
related increase in inflammatory markers. Moreover, endurance
training was associated with improved insulin sensitivity and
lower triglyceride levels, and these effects were independent of
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Fig. 2. CRP, IL-6 and suPAR. Level of (A) C-reactive protein (CRP), (B) interleukin-6
(IL-6) and (C) suPAR in plasma from the four different groups. All three variables
were log-transformed before statistical analyses, and CRP shown on a log scale on
the graph. p-Values from 2-way ANOVA are given in the figures. Data are shown as
mean + SE. N = 10–15 as given in Table 1.
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Fig. 3. TNFa and receptors. Level of (A) TNFa and the soluble receptors, (B) sTNFRI
and (C) sTNFRII in the four different groups. TNFa was measured in plasma and
sTNFRI & sTNFRII in serum. p-Values for 2-way ANOVA are given in the figures.
Significant difference between O-Un and O-Tr, *p < 0.05. Data are shown as
mean + SE. N = 10–15 is as given in Table 1.
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age. Furthermore, both age and training status were observed to
influence waist circumference, VO2 peak, total cholesterol, LDL, leg
muscle size, CRP and IL-6, although age and training exerted
opposing effects; aging generally affects these parameters in an
unhealthy direction, whereas endurance training influences them
in a health-promoting direction. Together these findings indicate
that regular endurance training may play a role in lowering some
markers of systemic inflammation – even within the normal range
– and in regulating important metabolic and physiological muscle
parameters with aging.
It has been suggested that the influence of physical training on
systemic inflammation is exerted through weight loss and a loss of
adipose tissue (Vieira et al., 2009). It would appear that the findings
of the present study support this, in that long distance running in
young and old healthy males was associated with lower levels of
CRP and IL-6 (Fig. 2). However, the participants of our study had a
BMI classification of normal weight, with low concentrations of
CRP (approximately 1 mg/L), in contrast to the study by Vieira,
where participants had a BMI classification of overweight and had
higher CRP values (approximately 3 mg/L). This suggests that
endurance exercise exerts a beneficial effect on systemic
inflammatory status, which is unrelated to overweight. In addition,
it is possible that the lower level of CRP and IL-6 in endurance
trained athletes is coupled to the maintenance of skeletal muscle
mass (Fig. 4). However, such a coupling is at this point speculative
and needs larger studies for confirmation.
With regard to muscle mass and strength, we found a greater
muscle size (Q-CSA) and muscle strength in young compared to old
men, and that endurance trained individuals had greater Q-CSA
and strength than their untrained counterparts (Fig. 1), which is in
accordance with previous observations (Galloway et al., 2002;
Tarpenning et al., 2004; Wiswell et al., 2001; Faulkner et al., 2008).
Within the young groups, quadriceps muscle strength was higher
in trained than in untrained individuals, which was not the case
within the old groups. This would seem to suggest that muscle
strength cannot be maintained by life-long endurance training.
However, it should be kept in mind that all participants were
selected and healthy, and thus are probably not representative of
the general aging population. Furthermore, it should be noted that
in spite of a training-associated difference in muscle cross sectional
area in elderly individuals, as mentioned above there was no
significant difference in quadriceps strength between O-Un and
O-Tr, which would indicate that the relative muscle force (per
muscle area) is lower in trained vs untrained. This is very unlikely
and points more towards a limitation in the strength data obtained
in the present study. Variation in the measurements of strength
was higher than in the CSA measurements (CV 19–31% vs 6–14%
for strength and CSA, respectively) and further differences between
groups in muscle strength may have emerged had a larger number
of subjects been studied.
As an indicator of aerobic capacity, we observed a higher VO2
peak in trained vs untrained, and that younger individuals had a
higher VO2 peak when compared to elderly individuals, regardless
of training status, which is supported by earlier reports (Hagberg
et al., 1998; Hawkins et al., 2001; Rogers et al., 1990; Wiswell et al.,
2001).
In this study, both aging and physical activity levels were
observed to influence blood cholesterol, LDL and to some extent
HDL (Table 2). Aging was associated with elevated total cholesterol
and LDL, but exercise training reduces these parameters (Table 2).
These findings support the isolated findings reported earlier on
aging and training (Leon and Sanchez, 2001; Vogel et al., 2009). Old
athletes have previously been shown to have more favourable lipid
profiles than sedentary subjects and even similar to those of young
adults (Yataco et al., 1997).
While we did not determine insulin sensitivity using eugly-
cemic, hyper-insulinaemic glucose clamp, but instead used
indirect methods, fasted insulin and indexes of insulin resistance
(HOMA-IR) and insulin sensitivity (QUICKI) were observed to be
more favourable in the trained than untrained state, as expected
(Seals et al., 1984; Henriksson, 1995; Ryan, 2000). Interestingly,
there was no effect of aging on these parameters, indicating that
age-related loss in insulin sensitivity is almost exclusively due to a
decline in physical activity level rather that to aging per se. This
supports the view that life-long physical endurance training can
maintain metabolic health in human skeletal muscle. In contrast to
insulin sensitivity, glucose levels (including HbA1c) were observed
to be affected by age but not by training status, indicating that
aging does affect glucose levels, despite the lack of influence on
insulin sensitivity. It should be noted here that the O-Un
individuals were screened not to have any morbidities or signs
of pre-morbidity and thus do not represent the general aging
population. We did this to separate out the exercise component as
much as possible from the aging process.
In large scale population-based studies, relationships between
inflammatory markers and loss of muscle mass and strength have
previously been observed (Visser et al., 2002; Schaap et al., 2009,
2006; Geffken et al., 2001; Taaffe et al., 2000; Yu et al., 2009;
Wannamethee et al., 2002; Reuben et al., 2003; Colbert et al., 2004;
Valentine et al., 2009). In the majority of the cross-sectional
studies, increasing time spent on physical activity was associated
with a reduced level of CRP, IL-6 and in a few cases TNFa. To our
knowledge, this is one of the first studies on systemic levels of
inflammatory markers in elderly athletes, including an age-
matched healthy control group, and a comparison to both trained
and untrained young counterparts. The positive effect of training
that we observed for CRP and IL-6 was as expected based on studies
showing that both of these inflammatory markers are usually
lower in well trained subjects and can be reduced by long-term
training (Nicklas et al., 2008; Kohut et al., 2006; Campbell et al.,
2009). Furthermore, we detected greater levels of CRP and IL-6 in
the old groups. Both CRP and IL-6 levels were very low in our
subjects (approximately 1 mg/l for CRP), which is somewhat in
contrast to earlier training studies that were mostly performed on
patients with CRP levels of about 4–5 mg/l (Nicklas et al., 2008;
Campbell et al., 2009). This supports the idea that, even within a
range of very low CRP values, circulating levels of biomarkers are
related to the degree of physical training.
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The increase in suPAR with age in the present study is in line
with prior studies although all suPAR concentrations in general
were low. SuPAR’s association with diseases related to a sedentary
lifestyle, such as diabetes and cardiovascular diseases, is well
established (Eugen-Olsen et al., 2010; Lyngbaek et al., 2013a), and
is similar to CRP. CRP in these settings is associated with
anthropometric measures, whereas suPAR is linked to endothelial
dysfunction and subclinical organ damage due to atherosclerosis
(Lyngbaek et al., 2013b). SuPARs are present on vascular
endothelial cells and involved in several immune functions
including migration, adhesion, angiogenesis, fibrinolysis and cell
proliferation (Eugen-Olsen et al., 2010), making it a potential
player in locally induced inflammation and regeneration. At the
time of writing, only one study on circulating levels of suPAR in
relation to exercise could be found, where, in well-trained young
individuals, no influence of an acute bout of exercise was detected
(Sanchis-Gomar et al., 2013), but it is clear that more data are
needed on any potential influence of exercise on suPAR and what
the implications of changed levels would be. The fact that suPAR
did not demonstrate any relationship to degree of physical activity
could be due to suPAR being a marker of minor pathology rather
than an effect of physical training itself. In this way suPAR cannot
be directly compared with the other markers of inflammation, but
we cannot rule out that we, in this study due to the low number of
subjects, may have overlooked any true effect of training on suPAR.
TNFa is considered a pro-inflammatory cytokine which
contributes to breakdown and wasting of skeletal muscle (Li
and Reid, 2001). In a 5-year study of 70-year olds, higher baseline
levels of several cytokines, but in particular TNFa and its soluble
receptors, were found to be associated with a greater decline in
thigh muscle area, even in weight-stable individuals (Schaap et al.,
2009). In the present study, the plasma levels of TNFa were
generally very low and yet higher levels were detected in the old
trained compared to old untrained. This was in contrast to our
hypothesis, since studies in elderly individuals have shown either
reduced (Phillips et al., 2012; Kohut et al., 2006; Ogawa et al., 2010;
Onambele-Pearson et al., 2010; Cordova et al., 2011) or unchanged
(Onambele-Pearson et al., 2010) circulating TNFa levels with
training, although mainly resistance training interventions were
used in these previous studies. The reduced TNFa level we
observed was not a general effect of training, since it was only
present in the old untrained. It is possible that an explanation for
this result lies in the age and excellent health status of the old
untrained in this study. Support for the latter is illustrated in the
similar muscle strength measured for the young untrained and old
untrained groups, indicating that the muscle of the old untrained
had not ‘‘aged’’ much from the point of view of function. It has
previously been reported that individuals in the age range 55–65
do not have elevated circulating TNFa levels compared to 18–30
year olds. However, greater levels were detected in 81-year olds
and even greater levels again in centenarians, suggesting that
TNFa levels do not rise with age until the ninth decade of life
(Bruunsgaard et al., 1999). The soluble receptors for TNF were both
slightly elevated in the old groups. An elevated circulating level of
the pro-inflammatory cytokine TNFa, number of TNFa receptors
and sensitivity to TNFa with increasing age has previously been
found in most (Bruunsgaard et al., 2000; Mariani et al., 2006;
Shurin et al., 2007; Stowe et al., 2010; Roubenoff, 2007) but not all
(Donato et al., 2008) studies. In the present study, the trained
groups had lower sTNFRI, whereas sTNFRII appeared unaffected by
training. We measured sTNFRs together with TNFa, since TNFa is
usually present at very low levels (particularly in healthy subjects)
whereas sTNFRs are present in the circulation at all times and can
be regarded as surrogate markers for TNFa (Stowe et al., 2010).
On average the old groups were 40 years older than the young
groups, and life-long endurance training among these elderly
individuals improved a number of the measured parameters (Q-
CSA, VO2peak, CRP, IL-6 and sTNFRI) to the levels observed among
the young individuals. Mostly corresponding to young untrained,
or sometimes even at level of the young trained, indicating that
life-long endurance trained athletes are similar to individuals 40
years younger in terms of inflammatory biomarker profile. It has
however to be mentioned that the low number of individuals in the
present study somewhat limits the overall conclusions that can be
drawn, and larger studies are needed to confirm our findings.
Clearly, the design of the present study was cross-sectional and
therefore no conclusions about cause and effect relationships
between physical activity, inflammatory markers and muscle mass
can be drawn. Nevertheless, the master athlete model is used as a
unique model for successful, optimal aging, and serves as an
example for physical activity to maintain health. Changes detected
in the old trained are considered to be the result of primary
(physiological) aging rather than secondary (lifestyle-related)
aging (Tanaka and Seals, 2003), and thus we suggest that life-
long endurance training could contribute to the changes observed
in physiological parameters between the groups.
5. Conclusion
In non-obese healthy males, endurance training was associated
with improved insulin sensitivity and lower triglyceride levels,
which was independent of age. Furthermore, age-related changes
in waist circumference, VO2 peak, cholesterol, LDL, leg muscle size,
CRP and IL-6 were counteracted by the effects of physical activity
level in the old (and young) groups. Finally, life-long endurance
exercise was associated with attenuation in both the age-related
elevation of some inflammatory markers (CRP and IL-6) and a
reduction in thigh muscle size. Overall, the findings in a limited
number of individuals suggest that regular physical endurance
activity may play a role both in reducing the systemic inflamma-
tion levels, even within a normal range of plasma concentration,
and for maintenance of muscle mass with aging.
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